文献速递自身炎症与 IgG4 相关病

COPA综合征中STING诱导的I型干扰素产生增强

Augmentation of Stimulator of Interferon Genes-Induced Type I Interferon Production in COPA Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2021-01-01

本研究在一个家系4例患者中鉴定出新型COPA变体c.725T>G(p.Val242Gly),患者I型干扰素评分升高;体外实验显示该变体及已知致病变体增强STING诱导的I型干扰素启动子活性;CopaV242G/+小鼠出现间质性肺病和STING依赖的干扰素刺激基因表达升高,提示该变体通过增强STING通路反应导致I型干扰素产生增加。

要点

  • 新型COPA变体V242G与COPA综合征相关,患者I型干扰素评分升高。
  • V242G变体增强STING诱导的I型干扰素启动子活性。
  • CopaV242G/+小鼠重现间质性肺病,且干扰素刺激基因表达升高依赖STING。

核心结论

  • COPA V242G变体通过增强STING通路反应导致I型干扰素产生增加,从而引起COPA综合征表现。

研究设计与样本

  • 对7名家庭成员进行全外显子测序并检测外周血细胞I型干扰素特征。
  • 进行体外实验分析COPA变体效应,并构建Copa突变小鼠模型。

主要发现

  • 在一个家系4例患者中鉴定出杂合COPA变体c.725T>G(p.Val242Gly),携带者IFN评分高。
  • 体外实验显示COPA V242G及既往报道的致病变体增强STING诱导的I型干扰素启动子活性。
  • CopaV242G/+小鼠表现为间质性肺病和STING依赖的干扰素刺激基因表达升高。
  • CopaV242G/+树突状细胞中STING通路非组成性激活,但刺激后过度激活,导致I型干扰素产生增加。

临床怎么用

  • 对疑似COPA综合征患者可考虑COPA基因检测,关注V242G等变体。
  • I型干扰素评分可能作为辅助评估指标。
  • 针对STING通路或I型干扰素的治疗策略可能对该病有益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Coatomer subunit alpha (COPA) syndrome, also known as autoinflammatory interstitial lung, joint, and kidney disease, is caused by heterozygous mutations in COPA. We identified a novel COPA variant in 4 patients in one family. We undertook this study to elucidate whether and how the variant causes manifestations of COPA syndrome by studying these 4 patients and by analyzing results from a gene-targeted mouse model. METHODS: We performed whole-exome sequencing in 7 family members and measured the type I interferon (IFN) signature of the peripheral blood cells. We analyzed the effects of COPA variants in in vitro experiments and in Copa mutant mice that were generated. RESULTS: We identified a heterozygous variant of COPA (c.725T>G, p.Val242Gly) in the 4 affected members of the family. The IFN score was high in the members carrying the variant. In vitro analysis revealed that COPA V242G, as well as the previously reported disease-causing variants, augmented stimulator of interferon genes (STING)-induced type I IFN promoter activities. CopaV242G/+ mice manifested interstitial lung disease and STING-dependent elevation of IFN-stimulated gene expression. In CopaV242G/+ dendritic cells, the STING pathway was not constitutively activated but was hyperactivated upon stimulation, leading to increased type I IFN production. CONCLUSION: V242G, a novel COPA variant, was found in 4 patients from one family. In gene-targeted mice with the V242G variant, interstitial lung disease was recapitulated and augmented responses of the STING pathway, leading to an increase in type I IFN production, were demonstrated.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Kato T, Yamamoto M, Honda Y, et al. Augmentation of Stimulator of Interferon Genes-Induced Type I Interferon Production in COPA Syndrome. Arthritis Rheumatol. 2021. PMID: 33982886. doi:10.1002/art.41790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。